The Times reports plans that could put Wegovy on Ireland's public health service, a potential shift in who can get the drug without paying privately.
Recap by typeshit. Full story at The Times.
The new Medicare program could cut GLP-1 costs by thousands for people on it, though many beneficiaries will not meet the eligibility rules.
KTSM breaks down which Medicare enrollees are eligible for GLP-1 drugs at a $50 monthly cost.
Men's Journal looks at the extra spending that comes with GLP-1 drugs beyond the prescription price, as these meds reshape weight loss.
Fifteen drugs, from Ozempic and Wegovy to Trelegy Ellipta, get Medicare negotiated prices that take effect January 1, 2027.
Reuters saw a Heineken presentation flagging GLP-1 drugs as a threat to beer sales, a rare admission from a major alcohol maker.
A hashtag page of personal Trulicity posts, including one user who says insurance denied Ozempic because she was only prediabetic.
Loading…